EUVIMEDEUVIMED entdecken
Multizentrische StudieKohortenstudieOpen Access · CC BY-NC 4.0

The Impact of Disease Activity and Medications on Pregnancy and Fetal Outcomes in Women With Inflammatory Bowel Disease: A Cohort Study From the IBD‐ME Group

Nahla Azzam iD, Majid Almadi, Heba Alfarhan, Mansour Altuwaijiri, Abdulrahman Aljebreen, Othman Alharbi, Mohammed Abaalkhail, Maryam Jaran, Abdulaziz Altamimi, Abdullah Al Theneyan, Nouf Al Turki, Lubna Alharbi und 3 weitere

Journal of Gastroenterology and Hepatology · 2026

DOI: 10.1111/jgh.70148 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Gastroenterology and Hepatology, 2026. Verfasst von Nahla Azzam und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Gastroenterology , College of Medicine, King Saud University, King Saud University Medical City, Riyadh, Saudi Ar…. Hauptthemen laut MEDLINE: Pregnancy Outcome, Pregnancy Complications, Inflammatory Bowel Diseases. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Women with inflammatory bowel disease (IBD) and their children are at higher risk of adverse outcomes. The primary aim was to examine the association between IBD and adverse pregnancy outcomes. The secondary aim was to assess the impact of maternal IBD and medications used on children's outcomes.

Methods

This is a multicenter retrospective study in Saudi Arabia and Kuwait. Three participating hospitals enrolled women with IBD who gave birth between 2016 and 2023. Information regarding disease characteristics, medication use, pregnancy outcomes, and long‐term health outcomes of children until age 14 years were collected.

Results

A total of 167 IBD pregnant women, a median age of 37.0 years (IQR: 33.0 to 44.0), were analyzed. Approximately 50% of women had three to six pregnancies. The most common pregnancy outcomes observed were low birth weight (22.5%) and small for gestational age (13.2%). A significant association was found between LBW and a history of smoking ( p = 0.024) and Crohn's disease compared with ulcerative colitis ( p = 0.018). Active flares or the need for steroids during pregnancy was significantly associated with adverse outcomes. 8.2% of the offspring were later diagnosed with IBD. A history of six or more pregnancies was identified as a significant predictor of IBD in offspring (OR = 4.02; 95% CI: 1.19–14.8, p < 0.01). None of the IBD medications used during pregnancy were associated with poor maternal or fetal outcomes.

Conclusions

Infants of women with active IBD are at an increased risk of prematurity and being small for gestational age. The number of pregnancies is a novel predictor for IBD in an offspring.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pregnancy OutcomePregnancy ComplicationsInflammatory Bowel DiseasesHumansFemalePregnancyAdultRetrospective StudiesSaudi ArabiaInfant, NewbornInfant, Small for Gestational AgeInfant, Low Birth WeightKuwaitCohort StudiesAdolescentColitis, UlcerativeSmoking

Autor:innen und Institutionen

  • Department of Medicine, Division of Gastroenterology , College of Medicine, King Saud University, King Saud University Medical City, Riyadh, Saudi Arabia.
  • Division of Gastroenterology, The McGill University Health Center, Montreal General Hospital, McGill University, Montreal, Canada.
  • Department of Internal Medicine, Division of Gastroenterology, Thunayan Al Ghanim Gastroenterology, Center at Al Amiri Hospital, Kuwait City, Kuwait.
  • Department of Internal Medicine, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Inflammatory Bowel Disease Unit, King Abdulaziz University Hospital, Jeddah, Saudi Arabia.

ORCID-Profile: Nahla Azzam, Mahmoud Mosli

Zitieren

APA

Azzam, N., Almadi, M., Alfarhan, H., Altuwaijiri, M., Aljebreen, A., Alharbi, O., Abaalkhail, M., Jaran, M., Altamimi, A., Al Theneyan, A., Al Turki, N., Alharbi, L., Ghamdi, J. A. L., Al Dakhil, A., & Mosli, M. (2026). The Impact of Disease Activity and Medications on Pregnancy and Fetal Outcomes in Women With Inflammatory Bowel Disease: A Cohort Study From the IBD‐ME Group. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.70148

Vancouver

Azzam N, Almadi M, Alfarhan H, Altuwaijiri M, Aljebreen A, Alharbi O, et al. The Impact of Disease Activity and Medications on Pregnancy and Fetal Outcomes in Women With Inflammatory Bowel Disease: A Cohort Study From the IBD‐ME Group. Journal of Gastroenterology and Hepatology. 2026. doi:10.1111/jgh.70148

BibTeX
@article{Azzam2026,
  author = {Azzam, Nahla and Almadi, Majid and Alfarhan, Heba and Altuwaijiri, Mansour and Aljebreen, Abdulrahman and Alharbi, Othman and Abaalkhail, Mohammed and Jaran, Maryam and Altamimi, Abdulaziz and Al Theneyan, Abdullah and Al Turki, Nouf and Alharbi, Lubna and Ghamdi, Joud A L and Al Dakhil, Amal and Mosli, Mahmoud},
  title = {The Impact of Disease Activity and Medications on Pregnancy and Fetal Outcomes in Women With Inflammatory Bowel Disease: A Cohort Study From the IBD‐ME Group},
  journal = {Journal of Gastroenterology and Hepatology},
  year = {2026},
  doi = {10.1111/jgh.70148}
}
Kostenlos starten →